P2Y Receptors in the Mammalian Nervous System

Pharmacology, Ligands and Therapeutic Potential

Gary A. Weisman, Lucas T. Woods, Laurie Erb, Cheikh Seye

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

P2Y receptors for extracellular nucleotides are coupled to activation of a variety of G proteins and stimulate diverse intracellular signaling pathways that regulate functions of cell types that comprise the central nervous system (CNS). There are 8 different subtypes of P2Y receptor expressed in cells of the CNS that are activated by a select group of nucleotide agonists. Here, the agonist selectivity of these 8 P2Y receptor subtypes is reviewed with an emphasis on synthetic agonists with high potency and resistance to degradation by extracellular nucleotidases that have potential applications as therapeutic agents. In addition, the recent identification of a wide variety of subtype-selective antagonists is discussed, since these compounds are critical for discerning cellular responses mediated by activation of individual P2Y receptor subtypes. The functional expression of P2Y receptor subtypes in cells that comprise the CNS is also reviewed and the role of each subtype in the regulation of physiological and pathophysiological responses is considered. Other topics include the role of P2Y receptors in the regulation of blood-brain barrier integrity and potential interactions between different P2Y receptor subtypes that likely impact tissue responses to extracellular nucleotides in the CNS. Overall, current research suggests that P2Y receptors in the CNS regulate repair mechanisms that are triggered by tissue damage, inflammation and disease and thus P2Y receptors represent promising targets for the treatment of neurodegenerative diseases.

Original languageEnglish
Pages (from-to)722-738
Number of pages17
JournalCNS and Neurological Disorders - Drug Targets
Volume11
Issue number6
DOIs
StatePublished - 2012

Fingerprint

Nervous System
Central Nervous System
Pharmacology
Ligands
Nucleotides
Nucleotidases
Therapeutics
Blood-Brain Barrier
GTP-Binding Proteins
Neurodegenerative Diseases
Inflammation
Research

Keywords

  • Neuroinflammation
  • P2Y receptor
  • P2Y receptor agonist
  • P2Y receptor antagonist

ASJC Scopus subject areas

  • Neuroscience(all)
  • Pharmacology

Cite this

P2Y Receptors in the Mammalian Nervous System : Pharmacology, Ligands and Therapeutic Potential. / Weisman, Gary A.; Woods, Lucas T.; Erb, Laurie; Seye, Cheikh.

In: CNS and Neurological Disorders - Drug Targets, Vol. 11, No. 6, 2012, p. 722-738.

Research output: Contribution to journalArticle

@article{bf3d53888de64158bb43a6724f123f95,
title = "P2Y Receptors in the Mammalian Nervous System: Pharmacology, Ligands and Therapeutic Potential",
abstract = "P2Y receptors for extracellular nucleotides are coupled to activation of a variety of G proteins and stimulate diverse intracellular signaling pathways that regulate functions of cell types that comprise the central nervous system (CNS). There are 8 different subtypes of P2Y receptor expressed in cells of the CNS that are activated by a select group of nucleotide agonists. Here, the agonist selectivity of these 8 P2Y receptor subtypes is reviewed with an emphasis on synthetic agonists with high potency and resistance to degradation by extracellular nucleotidases that have potential applications as therapeutic agents. In addition, the recent identification of a wide variety of subtype-selective antagonists is discussed, since these compounds are critical for discerning cellular responses mediated by activation of individual P2Y receptor subtypes. The functional expression of P2Y receptor subtypes in cells that comprise the CNS is also reviewed and the role of each subtype in the regulation of physiological and pathophysiological responses is considered. Other topics include the role of P2Y receptors in the regulation of blood-brain barrier integrity and potential interactions between different P2Y receptor subtypes that likely impact tissue responses to extracellular nucleotides in the CNS. Overall, current research suggests that P2Y receptors in the CNS regulate repair mechanisms that are triggered by tissue damage, inflammation and disease and thus P2Y receptors represent promising targets for the treatment of neurodegenerative diseases.",
keywords = "Neuroinflammation, P2Y receptor, P2Y receptor agonist, P2Y receptor antagonist",
author = "Weisman, {Gary A.} and Woods, {Lucas T.} and Laurie Erb and Cheikh Seye",
year = "2012",
doi = "10.2174/187152712803581047",
language = "English",
volume = "11",
pages = "722--738",
journal = "CNS and Neurological Disorders - Drug Targets",
issn = "1871-5273",
publisher = "Bentham Science Publishers B.V.",
number = "6",

}

TY - JOUR

T1 - P2Y Receptors in the Mammalian Nervous System

T2 - Pharmacology, Ligands and Therapeutic Potential

AU - Weisman, Gary A.

AU - Woods, Lucas T.

AU - Erb, Laurie

AU - Seye, Cheikh

PY - 2012

Y1 - 2012

N2 - P2Y receptors for extracellular nucleotides are coupled to activation of a variety of G proteins and stimulate diverse intracellular signaling pathways that regulate functions of cell types that comprise the central nervous system (CNS). There are 8 different subtypes of P2Y receptor expressed in cells of the CNS that are activated by a select group of nucleotide agonists. Here, the agonist selectivity of these 8 P2Y receptor subtypes is reviewed with an emphasis on synthetic agonists with high potency and resistance to degradation by extracellular nucleotidases that have potential applications as therapeutic agents. In addition, the recent identification of a wide variety of subtype-selective antagonists is discussed, since these compounds are critical for discerning cellular responses mediated by activation of individual P2Y receptor subtypes. The functional expression of P2Y receptor subtypes in cells that comprise the CNS is also reviewed and the role of each subtype in the regulation of physiological and pathophysiological responses is considered. Other topics include the role of P2Y receptors in the regulation of blood-brain barrier integrity and potential interactions between different P2Y receptor subtypes that likely impact tissue responses to extracellular nucleotides in the CNS. Overall, current research suggests that P2Y receptors in the CNS regulate repair mechanisms that are triggered by tissue damage, inflammation and disease and thus P2Y receptors represent promising targets for the treatment of neurodegenerative diseases.

AB - P2Y receptors for extracellular nucleotides are coupled to activation of a variety of G proteins and stimulate diverse intracellular signaling pathways that regulate functions of cell types that comprise the central nervous system (CNS). There are 8 different subtypes of P2Y receptor expressed in cells of the CNS that are activated by a select group of nucleotide agonists. Here, the agonist selectivity of these 8 P2Y receptor subtypes is reviewed with an emphasis on synthetic agonists with high potency and resistance to degradation by extracellular nucleotidases that have potential applications as therapeutic agents. In addition, the recent identification of a wide variety of subtype-selective antagonists is discussed, since these compounds are critical for discerning cellular responses mediated by activation of individual P2Y receptor subtypes. The functional expression of P2Y receptor subtypes in cells that comprise the CNS is also reviewed and the role of each subtype in the regulation of physiological and pathophysiological responses is considered. Other topics include the role of P2Y receptors in the regulation of blood-brain barrier integrity and potential interactions between different P2Y receptor subtypes that likely impact tissue responses to extracellular nucleotides in the CNS. Overall, current research suggests that P2Y receptors in the CNS regulate repair mechanisms that are triggered by tissue damage, inflammation and disease and thus P2Y receptors represent promising targets for the treatment of neurodegenerative diseases.

KW - Neuroinflammation

KW - P2Y receptor

KW - P2Y receptor agonist

KW - P2Y receptor antagonist

UR - http://www.scopus.com/inward/record.url?scp=84869019324&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84869019324&partnerID=8YFLogxK

U2 - 10.2174/187152712803581047

DO - 10.2174/187152712803581047

M3 - Article

VL - 11

SP - 722

EP - 738

JO - CNS and Neurological Disorders - Drug Targets

JF - CNS and Neurological Disorders - Drug Targets

SN - 1871-5273

IS - 6

ER -